Marshall Wace North America’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$47.5M Buy
+408,801
New +$51.2M 0.2% 104
2019
Q3
Sell
-63,596
Closed -$3.58M 1354
2019
Q2
$3.58M Buy
63,596
+18,453
+41% +$956K 0.02% 431
2019
Q1
$2.45M Buy
45,143
+43,871
+3,449% +$2.43M 0.02% 455
2018
Q4
$65K Sell
1,272
-31,531
-96% -$2.02M ﹤0.01% 1183
2018
Q3
$2.35M Buy
+32,803
New +$2.32M 0.02% 459
2018
Q2
Sell
-9,110
Closed -$601K 1457
2018
Q1
$601K Sell
9,110
-62,211
-87% -$4.57M ﹤0.01% 1115
2017
Q4
$5.15M Buy
71,321
+16,147
+29% +$994K 0.03% 568
2017
Q3
$3.25M Buy
55,174
+6,456
+13% +$389K 0.02% 670
2017
Q2
$3.17M Buy
+48,718
New +$3.23M 0.02% 621

Other funds holding DVA

Marshall Wace North America's DVA Position: Q3 2021 in Review

Marshall Wace North America opened a new position in DaVita (DVA) in Q3 2021: 408,801 shares worth $47.5M. The stake represents 0.2% of the portfolio and ranks #104 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in DVA as recently as Q2 2019.

Marshall Wace North America first reported a position in DVA in Q2 2017 and has held it in 9 quarters since. 511 funds tracked by Wall St. Rank hold DVA as of Q3 2021.

  • Marshall Wace North America held 408,801 shares of DaVita worth $47.5M as of Q3 2021.
  • DaVita was a new Marshall Wace North America position in Q3 2021.
  • DaVita made up 0.2% of Marshall Wace North America's portfolio in Q3 2021, its #104 holding.
  • Marshall Wace North America first reported a position in DaVita in Q2 2017 and has held it in 9 quarters since.
  • 511 funds tracked by Wall St. Rank held DaVita as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.